Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,486 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count.
Ikeda N, Imanishi H, Aizawa N, Tanaka H, Iwata Y, Enomoto H, Saito M, Iijima H, Iimuro Y, Fujimoto J, Yamamoto S, Hirota S, Kudo M, Arii S, Nishiguchi S. Ikeda N, et al. Among authors: iwata y. Hepatol Res. 2014 Aug;44(8):829-36. doi: 10.1111/hepr.12184. Epub 2013 Aug 7. Hepatol Res. 2014. PMID: 23763386
Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast-enhanced ultrasonography.
Tanaka H, Iijima H, Nouso K, Aoki N, Iwai T, Takashima T, Sakai Y, Aizawa N, Iwata K, Ikeda N, Iwata Y, Enomoto H, Saito M, Imanishi H, Nishiguchi S. Tanaka H, et al. Among authors: iwata y, iwata k. Hepatol Res. 2012 Apr;42(4):376-84. doi: 10.1111/j.1872-034X.2011.00936.x. Epub 2012 Jan 3. Hepatol Res. 2012. PMID: 22221694
Hepatitis C virus relapse was suppressed by long-term self-injection of low-dose interferon in patients with chronic hepatitis C after pegylated interferon plus ribavirin treatment.
Takashima T, Enomoto H, Ninomiya T, Kim SR, Okushin H, Sugano M, Imoto S, Yano Y, Ooka T, Seo Y, Kasugai H, Muramatsu A, Jomura H, Shimomura S, Shindo M, Nakamura H, Aizawa N, Iwata Y, Saito M, Imanishi H, Iijma H, Nishiguchi S. Takashima T, et al. Among authors: iwata y. Hepatol Res. 2014 Jun;44(6):597-607. doi: 10.1111/hepr.12153. Epub 2013 May 31. Hepatol Res. 2014. PMID: 23639109
Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis.
Nishikawa H, Enomoto H, Iwata Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S. Nishikawa H, et al. Among authors: iwata y. Hepatol Res. 2016 Jun;46(7):613-21. doi: 10.1111/hepr.12596. Epub 2015 Nov 5. Hepatol Res. 2016. PMID: 26406984
Impact of serum Wisteria floribunda agglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis.
Nishikawa H, Enomoto H, Iwata Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Ishii A, Iijima H, Nishiguchi S. Nishikawa H, et al. Among authors: iwata y. Hepatol Res. 2016 May;46(6):575-83. doi: 10.1111/hepr.12595. Epub 2015 Nov 5. Hepatol Res. 2016. PMID: 26418076
Comparison of sleep disorders in chronic hepatitis C patients treated with interferon-based therapy and direct acting antivirals using actigraphy.
Yoh K, Nishikawa H, Enomoto H, Iwata Y, Kishino K, Shimono Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Ishii A, Iijima H, Matsunaga H, Nakamura H, Nishiguchi S. Yoh K, et al. Among authors: iwata y. Hepatol Res. 2016 Dec;46(13):1358-1366. doi: 10.1111/hepr.12694. Epub 2016 Apr 4. Hepatol Res. 2016. PMID: 26950182
Clinical implications of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein in treatment-naïve chronic hepatitis B.
Ishii A, Nishikawa H, Enomoto H, Iwata Y, Kishino K, Shimono Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S. Ishii A, et al. Among authors: iwata y. Hepatol Res. 2017 Feb;47(2):204-215. doi: 10.1111/hepr.12703. Epub 2016 May 2. Hepatol Res. 2017. PMID: 26990490
Prognostic significance of low skeletal muscle mass compared with protein-energy malnutrition in liver cirrhosis.
Nishikawa H, Enomoto H, Ishii A, Iwata Y, Miyamoto Y, Ishii N, Yuri Y, Takata R, Hasegawa K, Nakano C, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S. Nishikawa H, et al. Among authors: iwata y. Hepatol Res. 2017 Sep;47(10):1042-1052. doi: 10.1111/hepr.12843. Epub 2017 Jan 17. Hepatol Res. 2017. PMID: 27862791
1,486 results